Recent advancements in GLP-1 receptor agonist are focusing on advanced administration methods, especially the development of swiftly disintegrating formulations. These unique methods intend to improve user ease of use and potentially provide quicker action, resulting to better therapeutic results. Experts believe that this platform presents signifi